Kim Kramer

Sloan-Kettering Institute For Cancer Res

$2,359,989

Attributed

$2,359,989

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $598.1K · FY2005–08

$1M$750K$500K$250K$0

'05

'06

'07

'08

Funding mix

By agency

NIH$1,620,825 · 3

FDA$739,164 · 1

By mechanism

R21$1,448,025 · 2

R01$739,164 · 1

K08$172,800 · 1

Top collaborators

No co-investigators on record.

Most similar at Sloan-Kettering Institute For Cancer Res

Same institution · by research overlap

Others in their field

Top investigators on “Monoclonal Antibody”

Bambra Strokes · Ppd Development Lp$461,655,950
Glenda E Gray · Wits Health Consortium (Pty), Ltd$276,346,332
Lawrence Corey · Fred Hutchinson Cancer Center$271,417,082
Margaret Juliana McElrath · Fred Hutchinson Cancer Center$257,261,947
Peter B. Gilbert · Fred Hutchinson Cancer Center$190,281,881
Barton F Haynes · Duke University$125,632,198

Research focus

Monoclonal AntibodyClinical Trial Phase IGangliosidesHuman SubjectIodineClinical ResearchPharmacokineticsRadiation Therapy DosageCentral Nervous System NeoplasmsNeoplasm /Cancer Radionuclide TherapyNeoplasm /Cancer ImmunotherapyNeoplasm /Cancer RadioimmunotherapyRadionuclidesRadiotracerSingle Photon Emission Computed TomographyAntitumor AntibodySpinal Cord DisordersBinding ProteinsBiotinClearance RateDrug Administration RoutesDrug Screening /EvaluationHuman Therapy EvaluationImmunoconjugates